Close Menu

NEW YORK (GenomeWeb) – Danaher today reported an 11 percent year-over-year increase in its fourth quarter revenues, with its Life Sciences and Diagnostics segments growing above the companywide rate.

Danaher also announced a transition plan for Daniel Comas, who will step down as CFO on Jan. 1, 2019, to be replaced by Matthew McGrew.

For the three months ended Dec. 31, 2017, total revenues came in at $5.09 billion, up from $4.58 billion in the year-ago period, and beating the consensus Wall Street estimate of $4.98 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

People reports that researchers have uncovered genetic variants that lead people to always feel full.

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.